Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus

Objective. Assessment of the effect of a treatment method change from multiple daily insulin injection (MDI) to continuous subcutaneous insulin infusion (CSII) on the development of early angiopathy in children with T1DM with or without retinopathy. Methods. The study pump group involved 32 diabetic...

Full description

Saved in:
Bibliographic Details
Main Authors: Joanna Tołwińska, Barbara Głowińska-Olszewska, Artur Bossowski
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/791283
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550384474783744
author Joanna Tołwińska
Barbara Głowińska-Olszewska
Artur Bossowski
author_facet Joanna Tołwińska
Barbara Głowińska-Olszewska
Artur Bossowski
author_sort Joanna Tołwińska
collection DOAJ
description Objective. Assessment of the effect of a treatment method change from multiple daily insulin injection (MDI) to continuous subcutaneous insulin infusion (CSII) on the development of early angiopathy in children with T1DM with or without retinopathy. Methods. The study pump group involved 32 diabetic children aged 14.8, with the initial HbA1c level of 8.3%, previously treated by MDI. The patients were examined before pump insertion and after 3 and 6 months of CSII. We assessed HbA1c level, carotid artery intima-media thickness (c-IMT), and flow-mediated dilatation (FMD) of the brachial artery. The pump group was compared to a group of eight teenagers with diagnosed nonproliferative retinopathy, treated with MDI. Results. HbA1c in the entire group was found to improve in the second and in the third examination. During 6 months of CSII, FMD increased and IMT decreased. Retinopathic adolescents had significantly thicker IMT and lower FMD compared to baseline results of the pump group. Treatment intensification in the retinopathy-free children enhanced these differences. Conclusions. CSII is associated with lower IMT and higher FMD. Whether on the long-run CSII is superior to MDI to delay the occurrence of diabetes late complications remains to be explained.
format Article
id doaj-art-e1d6d38fa74a49c78865884e484039fd
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-e1d6d38fa74a49c78865884e484039fd2025-02-03T06:06:59ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/791283791283Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes MellitusJoanna Tołwińska0Barbara Głowińska-Olszewska1Artur Bossowski2Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University of Białystok, Białystok University Children's Hospital, 17 Waszyngtona Street, 15-274 Bialystok, PolandDepartment of Pediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University of Białystok, Białystok University Children's Hospital, 17 Waszyngtona Street, 15-274 Bialystok, PolandDepartment of Pediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University of Białystok, Białystok University Children's Hospital, 17 Waszyngtona Street, 15-274 Bialystok, PolandObjective. Assessment of the effect of a treatment method change from multiple daily insulin injection (MDI) to continuous subcutaneous insulin infusion (CSII) on the development of early angiopathy in children with T1DM with or without retinopathy. Methods. The study pump group involved 32 diabetic children aged 14.8, with the initial HbA1c level of 8.3%, previously treated by MDI. The patients were examined before pump insertion and after 3 and 6 months of CSII. We assessed HbA1c level, carotid artery intima-media thickness (c-IMT), and flow-mediated dilatation (FMD) of the brachial artery. The pump group was compared to a group of eight teenagers with diagnosed nonproliferative retinopathy, treated with MDI. Results. HbA1c in the entire group was found to improve in the second and in the third examination. During 6 months of CSII, FMD increased and IMT decreased. Retinopathic adolescents had significantly thicker IMT and lower FMD compared to baseline results of the pump group. Treatment intensification in the retinopathy-free children enhanced these differences. Conclusions. CSII is associated with lower IMT and higher FMD. Whether on the long-run CSII is superior to MDI to delay the occurrence of diabetes late complications remains to be explained.http://dx.doi.org/10.1155/2013/791283
spellingShingle Joanna Tołwińska
Barbara Głowińska-Olszewska
Artur Bossowski
Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
Mediators of Inflammation
title Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
title_full Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
title_fullStr Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
title_full_unstemmed Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
title_short Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
title_sort insulin therapy with personal insulin pumps and early angiopathy in children with type 1 diabetes mellitus
url http://dx.doi.org/10.1155/2013/791283
work_keys_str_mv AT joannatołwinska insulintherapywithpersonalinsulinpumpsandearlyangiopathyinchildrenwithtype1diabetesmellitus
AT barbaragłowinskaolszewska insulintherapywithpersonalinsulinpumpsandearlyangiopathyinchildrenwithtype1diabetesmellitus
AT arturbossowski insulintherapywithpersonalinsulinpumpsandearlyangiopathyinchildrenwithtype1diabetesmellitus